Finerenone: Reducing Progressive Kidney Dysfunction and Secondary Cardiovascular Complications in Patients With Chronic Kidney Disease Associated With Type 2 Diabetes

被引:0
|
作者
Beacom, Robin E. [1 ]
Blankenship, James K. [2 ]
Harrington, Deedra H. [2 ]
机构
[1] Univ Louisiana Lafayette, Coll Nursing & Hlth Sci, Lafayette, LA 70504 USA
[2] Univ Louisiana, Coll Nursing & Hlth Sci, Lafayette, LA USA
来源
关键词
D O I
10.1016/j.nurpra.2022.04.009
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
[No abstract available]
引用
收藏
页码:800 / 801
页数:2
相关论文
共 50 条
  • [41] Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
    Filippatos, Gerasimos
    Anker, Stefan D.
    August, Phyllis
    Coats, Andrew J. S.
    Januzzi, James L.
    Mankovsky, Boris
    Rossing, Peter
    Ruilope, Luis M.
    Pitt, Bertram
    Sarafidis, Pantelis
    Teerlink, John R.
    Kapelios, Chris J.
    Gebel, Martin
    Brinker, Meike
    Joseph, Amer
    Lage, Andrea
    Bakris, George
    Agarwal, Rajiv
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (02) : 183 - 191
  • [42] Blood pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
    Ruilope, Luis M.
    Agarwal, Rajiv
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Sarafidis, Pantelis
    Schmieder, Roland E.
    Joseph, Amer
    Rethemeier, Nicole
    Nowack, Christina
    Bakris, George L.
    HYPERTENSION, 2022, 79 (12) : 2685 - 2695
  • [44] TYPE 2 DIABETES, CHRONIC KIDNEY DISEASE, AND MORTALITY IN PATIENTS WITH ESTABLISHED CARDIOVASCULAR DISEASE
    Saely, Christoph
    Vonbank, Alexander
    Lins, Christina
    Zanolin, Daniela
    Leiherer, Andreas
    Rein, Philipp
    Muendlein, Axel
    Drexel, Heinz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1841 - 1841
  • [45] Incidence of Chronic Kidney Disease and Progression of Kidney Dysfunction Among Patients With and Without Type 2 Diabetes
    Nichols, Gregory A.
    Derauz-Luyet, Anouk
    Hauske, Sibylle J.
    Brodovicz, Kimberly G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 482 - 482
  • [46] TYPE 2 DIABETES, CHRONIC KIDNEY DISEASE, AND MORTALITY IN PATIENTS WITH ESTABLISHED CARDIOVASCULAR DISEASE
    Saely, C. H.
    Vonbank, A.
    Lins, C.
    Zanolin, D.
    Leiherer, A.
    Mader, A.
    Larcher, B.
    Muendlein, A.
    Drexel, H.
    ATHEROSCLEROSIS, 2018, 275 : E202 - E203
  • [47] Type 2 diabetes, chronic kidney disease, and mortality in patients with established cardiovascular disease
    Saely, C. H.
    Vonbank, A.
    Lins, C.
    Zanolin, D.
    Leiherer, A.
    Mader, A.
    Larcher, B.
    Muendlein, A.
    Drexel, H.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 : 156 - 156
  • [48] Type 2 diabetes, chronic kidney disease, and mortality in patients with established cardiovascular disease
    Saely, Christoph
    Vonbank, Alexander
    Lins, Christina
    Zanolin, Daniela
    Leiherer, Andreas
    Schuler, Alexandra
    Ebner, Karl-Martin
    Rein, Philipp
    Schwerzler, Peter
    Mader, Arthur
    Muendlein, Axel
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S128 - S128
  • [49] Type 2 diabetes, chronic kidney disease, and mortality in patients with established cardiovascular disease
    Saely, C. H.
    Vonbank, A.
    Lins, C.
    Zanolin, D.
    Leiherer, A.
    Schuler, A.
    Schwerzler, P.
    Mader, A.
    Rein, P.
    Muendlein, A.
    Drexel, H.
    EUROPEAN HEART JOURNAL, 2017, 38 : 324 - 324
  • [50] Type 2 diabetes, chronic kidney disease, and mortality in patients with established cardiovascular disease
    Saely, Christoph
    Vonbank, Alexander
    Lins, Christina
    Zanolin, Daniela
    Leiherer, Andreas
    Ebner, Karl-Martin
    Schwerzler, Peter
    Mader, Arthur
    Heinzle, Christine
    Muendlein, Axel
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : 170 - 170